STOCK TITAN

Electromed Stock Price, News & Analysis

ELMD NYSE

Company Description

Overview

Electromed Inc is a Minnesota-based company specializing in the development, manufacturing, and global distribution of innovative medical devices focused on airway clearance therapy. At the heart of its product lineup is the cutting-edge SmartVest Airway Clearance System, which utilizes high frequency chest wall oscillation (HFCWO). This patented technology is designed to deliver effective yet comfortable treatment for patients suffering from conditions that result in compromised pulmonary function.

Core Technology and Product Offerings

The SmartVest system is a hallmark of medical device innovation in pulmonary care. It works by generating programmed air pulses through a specially designed garment, which is worn comfortably over the upper body. This process facilitates vigorous mucus clearance, thereby helping to manage symptoms associated with chronic respiratory conditions such as COPD, cystic fibrosis, bronchiectasis, atelectasis, and neuromuscular disorders.

  • High Frequency Chest Wall Oscillation (HFCWO): A key technological feature that offers an effective alternative to traditional chest physiotherapy.
  • Comfort and Safety: The design ensures that therapy remains well tolerated, promoting compliance among patients.
  • Clinical Validation: The treatment modality has been clinically tested to demonstrate its efficacy in clearing airway secretions and reducing lung infections.

Business Model and Market Position

Electromed generates revenue primarily through the direct sale of its SmartVest system and related products. The company is positioned within the broader healthcare technology and medical devices industry, where stringent regulatory standards and clinical efficacy are paramount. A significant aspect of the company’s market presence involves the continuous commitment to enhancing patient care by using technology that provides a safer and more effective treatment option than conventional methods.

Regulatory and Quality Standards

In the realm of medical devices, adherence to quality and safety protocols is crucial. Electromed maintains a robust certification profile, being accredited by the Joint Commission and certified to standards such as ISO 13485:2003 and ISO 9001:2008. These credentials attest to the company’s adherence to rigorous manufacturing processes and quality management systems, which are essential for ensuring the reliability and safety of its products.

Clinical Impact and Patient Benefits

The clinical utility of the SmartVest system is underscored by its ability to manage and alleviate the symptoms of a variety of pulmonary disorders. Patients benefit from a treatment that is not only effective in clearing airways but also designed to maximize comfort and usability. The system’s evolution reflects innovative responsiveness to clinical needs, contributing to improvements in patient quality of life and overall respiratory health management.

Industry Standing and Competitive Landscape

Within the competitive landscape of airway clearance solutions, Electromed distinguishes itself through its focus on combining technological innovation with stringent quality control. The company’s emphasis on safety, regulatory compliance, and clinical efficacy positions it as a trusted entity among healthcare providers and patients. While the market comprises various devices aiming to improve pulmonary function, Electromed’s strategic focus on HFCWO and its proven clinical benefits set it apart as a specialized and reliable provider.

Expertise and Authoritativeness in Healthcare Technology

Electromed Inc demonstrates a profound commitment to enhancing treatment regimens for respiratory disorders through its advanced medical technologies. Its products are firmly rooted in clinical research and regulatory best practices, making them a reference point for experts in the field. The company’s dedication to meeting high standards of performance and safety underscores its reputation for excellence in healthcare technology.

Summary

The innovative approach adopted by Electromed Inc, particularly through its SmartVest system, reflects its deep-rooted expertise in airway clearance therapy. The company manages to effectively combine state-of-the-art technology with a rigorous quality system to offer a product that improves respiratory care for individuals with complex pulmonary conditions. This comprehensive approach, backed by clinical validation and high regulatory standards, makes Electromed a distinctive presence in the medical device industry.

Stock Performance

$—
0.00%
0.00
Last updated:
18.8 %
Performance 1 year
$166.2M
Market Cap
8.4M
Shares outstanding

SEC Filings

No SEC filings available for Electromed.

Financial Highlights

$16,255,000
Revenue (TTM)
$1,968,000
Net Income (TTM)
$0.22
Diluted EPS (TTM)
$3,151,000
Operating Cash Flow
12.11%
Net Profit Margin
15.64%
Oper. Profit Margin

Upcoming Events

June 27, 2025
Index inclusion
Added to Russell 2000 & 3000 indices effective June 27, 2025 per FTSE Russell reconstitution

Frequently Asked Questions

What is the current stock price of Electromed (ELMD)?

The current stock price of Electromed (ELMD) is $20.07 as of June 17, 2025.

What is the market cap of Electromed (ELMD)?

The market cap of Electromed (ELMD) is approximately 166.2M.

What is the revenue (TTM) of Electromed (ELMD) stock?

The trailing twelve months (TTM) revenue of Electromed (ELMD) is $16,255,000.

What is the net income of Electromed (ELMD)?

The trailing twelve months (TTM) net income of Electromed (ELMD) is $1,968,000.

What is the earnings per share (EPS) of Electromed (ELMD)?

The diluted earnings per share (EPS) of Electromed (ELMD) is $0.22 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Electromed (ELMD)?

The operating cash flow of Electromed (ELMD) is $3,151,000.

What is the profit margin of Electromed (ELMD)?

The net profit margin of Electromed (ELMD) is 12.11%.

What is the operating margin of Electromed (ELMD)?

The operating profit margin of Electromed (ELMD) is 15.64%.

What is the gross margin of Electromed (ELMD)?

The gross profit margin of Electromed (ELMD) is 77.68%.

What is the current ratio of Electromed (ELMD)?

The current ratio of Electromed (ELMD) is 5.10, indicating the company's ability to pay short-term obligations.

What is the gross profit of Electromed (ELMD)?

The gross profit of Electromed (ELMD) is $12,627,000 on a trailing twelve months (TTM) basis.

What is the operating income of Electromed (ELMD)?

The operating income of Electromed (ELMD) is $2,542,000.

What is the primary focus of Electromed Inc?

Electromed Inc specializes in developing, manufacturing, and marketing medical devices focused on airway clearance therapy, predominantly through its SmartVest system which utilizes high frequency chest wall oscillation (HFCWO).

How does the SmartVest system work?

The SmartVest system employs a programmable air pulse generator connected to a wearable garment, delivering controlled chest wall oscillation that facilitates effective mucus clearance for patients with respiratory conditions.

What conditions can benefit from Electromed's technology?

Patients suffering from conditions such as COPD, cystic fibrosis, bronchiectasis, atelectasis, and various neuromuscular disorders can benefit from the airway clearance therapy provided by the SmartVest system.

Which regulatory standards does Electromed adhere to?

Electromed is accredited by the Joint Commission and holds certifications including ISO 13485:2003 and ISO 9001:2008, ensuring adherence to rigorous quality and safety standards in its manufacturing processes.

How does Electromed differentiate itself from competitors?

The company distinguishes itself through its innovative use of HFCWO technology, a strong commitment to clinical efficacy, and a robust quality management system that ensures patient safety and product reliability.

What is the significance of HFCWO in respiratory care?

High frequency chest wall oscillation (HFCWO) is a critical technology that enhances airway clearance by delivering effective yet comfortable treatment, offering an improved alternative to traditional chest physiotherapy methods.

Who are the primary customers of Electromed's products?

The company primarily serves healthcare providers, clinics, and institutions focused on respiratory care, as well as patients who require effective airway clearance as part of their treatment regimens.

What role do clinical validations play in Electromed's offerings?

Clinical validations ensure that Electromed's products meet strict efficacy and safety benchmarks, reinforcing the company's reputation for reliability and reinforcing trust among healthcare professionals.